Login / Signup

A patent review on aldehyde dehydrogenase inhibitors: an overview of small molecule inhibitors from the last decade.

Biswajit KunduMalliga R Iyer
Published in: Expert opinion on therapeutic patents (2023)
Aldehyde dehydrogenase (ALDH) is an important enzyme that metabolizes reactive exogenous and endogenous aldehydes in the body through NAD(P)±dependent oxidation. Hence this family of enzymes possess important physiological as well as toxicological roles in human body. Significant efforts in the field have led to potent inhibitors with approved clinical agents for alcohol use disorder therapy. Further clinical translation of novel compounds targeting ALDH inhibition will validate the promised therapeutic potential in treating many human diseases.The scientific/patent literature has been searched on SciFinder-n, Reaxys, PubMed, Espacenet and Google Patents. The search terms used were 'ALDH inhibitors', 'Aldehyde Dehydrogenase Inhibitors'.
Keyphrases
  • small molecule
  • endothelial cells
  • systematic review
  • stem cells
  • nitric oxide
  • bone marrow
  • quality improvement
  • pluripotent stem cells
  • cell therapy
  • protein protein